{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:47Z","timestamp":1786991627720,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015079","name":"ARUP Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015079","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jcf.2025.10.011","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:39:14Z","timestamp":1762324754000},"page":"38-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Persistent plasma and RBC fatty acid abnormalities in children and adolescents with cystic fibrosis on highly effective CFTR modulators"],"prefix":"10.1016","volume":"25","author":[{"given":"Tatiana","family":"Yuzyuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayode","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Zuromski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8489-0930","authenticated-orcid":false,"given":"Irene","family":"De Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6437-2447","authenticated-orcid":false,"given":"Nicole","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6211-3535","authenticated-orcid":false,"given":"Suzanne","family":"Meihls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-6845","authenticated-orcid":false,"given":"Fadi","family":"Asfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.10.011_bib0001","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa021218","article-title":"Association of cystic fibrosis with abnormalities in fatty acid metabolism","volume":"350","author":"Freedman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2025.10.011_bib0002","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MPG.0000000000001356","article-title":"Complex relation between diet and phospholipid fatty acids in children with cystic fibrosis","volume":"64","author":"Moukarzel","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0003","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004310050750","article-title":"Essential fatty acid deficiency in well nourished young cystic fibrosis patients","volume":"156","author":"Roulet","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0004","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.3390\/ijms150916083","article-title":"Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications","volume":"15","author":"Seegmiller","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcf.2025.10.011_bib0005","first-page":"14","article-title":"Nutrition in cystic fibrosis-some notes on the fat recommendations","author":"Strandvik","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2025.10.011_bib0006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000477913","article-title":"Serum phospholipid fatty acid composition in cystic fibrosis patients with and without liver cirrhosis","volume":"71","author":"Drzymala-Czyz","year":"2017","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jcf.2025.10.011_bib0007","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1067\/mpd.2001.118890","article-title":"Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis","volume":"139","author":"Strandvik","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0008","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000114208","article-title":"Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients","volume":"51","author":"Van Biervliet","year":"2007","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jcf.2025.10.011_bib0009","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcf.2025.10.011_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1373\/clinchem.2007.094623","article-title":"Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis","volume":"54","author":"Coste","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcf.2025.10.011_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111153","article-title":"Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?","volume":"27","author":"Drzymala-Czyz","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jcf.2025.10.011_bib0012","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1042\/CS20220450","article-title":"The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models","volume":"136","author":"Uc","year":"2022","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jcf.2025.10.011_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.2004-2832","article-title":"Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis","volume":"117","author":"Shoff","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2025.10.011_bib0014","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcf.2018.01.006","article-title":"Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis","volume":"17","author":"Sanders","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1017\/S000711450780105X","article-title":"Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis","volume":"99","author":"Gronowitz","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(89)80072-1","article-title":"Effect on renal function of essential fatty acid supplementation in cystic fibrosis","volume":"115","author":"Strandvik","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0017","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1183\/09031936.00000906","article-title":"Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis","volume":"29","author":"Durieu","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.10.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102156","article-title":"Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms","volume":"160","author":"Wheelock","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jcf.2025.10.011_bib0019","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPG.0b013e31817fb76b","article-title":"Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis","volume":"47","author":"Maqbool","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jcf.2019.12.007","article-title":"Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity","volume":"19","author":"Sagel","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0021","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Clinical Practice Guidelines on G, Nutrition, Subcommittee, Ad Hoc Working G. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jcf.2025.10.011_bib0022","article-title":"Omega-3 fatty acid supplementation for cystic fibrosis","volume":"4","author":"Watson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2025.10.011_bib0023","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/ncp.10605","article-title":"Variations in nutrition practices in cystic fibrosis: a survey of the digest program","volume":"36","author":"Shaikhkhalil","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcf.2025.10.011_bib0024","series-title":"Cystic fibrosis foundation patient registry highlights","year":"2023"},{"key":"10.1016\/j.jcf.2025.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcf.2023.07.001","article-title":"Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy","volume":"22","author":"Yuzyuk","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0026","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0027","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jcf.2023.04.019","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis","volume":"22","author":"Schembri","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0028","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1513\/AnnalsATS.202312-1065OC","article-title":"Multisystemic effects of elexacaftor-tezacaftor-ivacaftor in adults with cystic fibrosis and advanced lung disease","volume":"21","author":"Burgel","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2025.10.011_bib0029","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcf.2016.07.006","article-title":"The effects of ivacaftor on cf fatty acid metabolism: an analysis from the goal study","volume":"16","author":"O'Connor","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jcf.2023.04.010","article-title":"Changes in nutrition and growth status in young children in the first 12 weeks of ivacaftor therapy","volume":"22","author":"Tindall","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0031","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jcf.2024.05.005","article-title":"Impact of lumacaftor\/ivacaftor on nutrition and growth in modulator-naive children over 24 weeks","volume":"23","author":"Tindall","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102211","article-title":"Effect of fasting status and other pre-analytical variables on quantitation of long-chain fatty acids in red blood cells","volume":"163","author":"Lozier","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jcf.2025.10.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00082-2019","article-title":"Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles","volume":"5","author":"Taylor-Cousar","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcf.2025.10.011_bib0034","unstructured":"https:\/\/www.cff.org\/medical-professionals\/pancreatic-enzymes-clinical-care-guidelines CFFPeccg."},{"key":"10.1016\/j.jcf.2025.10.011_bib0035","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD clinical practice consensus guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2025.10.011_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinms.2016.12.001","article-title":"Quantitation of total fatty acids in plasma and serum by GC-NCI-MS","volume":"2","author":"Kish-Trier","year":"2016","journal-title":"Clin Mass Spectrom"},{"key":"10.1016\/j.jcf.2025.10.011_bib0037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2021.07.013","article-title":"Establishing age-stratified red blood cell fatty acid reference ranges using model-based clustering and iterative application of the Harris-Boyd method","volume":"97","author":"Balogun","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jcf.2025.10.011_bib0038","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jand.2019.01.003","article-title":"The relative contribution of food groups to macronutrient intake in children with cystic fibrosis: a european multicenter assessment","volume":"119","author":"Calvo-Lerma","year":"2019","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcf.2025.10.011_bib0039","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2018.03.011","article-title":"Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis","volume":"17","author":"Sutherland","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061801","article-title":"Change in nutrient and dietary intake in european children with cystic fibrosis after a 6-month intervention with a self-management mHealth tool","volume":"13","author":"Calvo-Lerma","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2025.10.011_bib0042","unstructured":"Saturated fatty acid and trans-fatty acid intake for adults and children: who guideline, Vol. Geneva, 2023."},{"key":"10.1016\/j.jcf.2025.10.011_bib0043","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jcf.2017.02.010","article-title":"Dietary intake and lipid profile in children and adolescents with cystic fibrosis","volume":"16","author":"Woestenenk","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.10.011_bib0044","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1079\/BJN19940199","article-title":"Plasma lipid concentrations in children with cystic fibrosis: the value of a high-fat diet and pancreatic supplementation","volume":"71","author":"Burdge","year":"1994","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jcf.2025.10.011_bib0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/gut.52.8.1159","article-title":"Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas","volume":"52","author":"Ahmed","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2025.10.011_bib0046","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2025.10.011_bib0047","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00671-2021","article-title":"The rescue of F508del-CFTR by elexacaftor\/tezacaftor\/ivacaftor (trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor","volume":"59","author":"Becq","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.10.011_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1114584","article-title":"Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy","volume":"14","author":"Stanke","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2025.10.011_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(21)01086-9","article-title":"P059 a double-blind randomised multi-centre european study of linoleic acid supplementation for one year in patients with cystic fibrosis","volume":"20","author":"Strandvik","year":"2021","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2025.10.011_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052739","article-title":"Is the ENaC dysregulation in cf an effect of protein-lipid interaction in the membranes?","volume":"22","author":"Strandvik","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325024956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325024956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:11:35Z","timestamp":1768878695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325024956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1569199325024956"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.10.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent plasma and RBC fatty acid abnormalities in children and adolescents with cystic fibrosis on highly effective CFTR modulators","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}